The bioimpedance analyzers market size has grown rapidly in recent years. It will grow from $0.67 billion in 2025 to $0.76 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to growth in fitness and wellness awareness, rising use of body composition assessment in sports and rehabilitation, early adoption of bioimpedance devices in hospitals and nutrition clinics, demand for non-invasive and rapid assessment technologies, expansion of fitness club and wellness center infrastructure.
The bioimpedance analyzers market size is expected to see rapid growth in the next few years. It will grow to $1.28 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing prevalence of obesity and metabolic disorders, growing demand for personalized health and fitness tracking, higher adoption of wireless and connected bioimpedance analyzers, rising use of multi-frequency analyzers for advanced body composition insights, expanding home user and remote health monitoring applications. Major trends in the forecast period include increasing use of bioimpedance analyzers for body composition monitoring, growing adoption in fitness, wellness, and weight management programs, rising utilization in clinical and hospital-based nutritional assessment, expansion of segmental and whole-body measurement applications, focus on accuracy, convenience, and non-invasive assessment techniques.
The growing concerns over obesity are anticipated to drive the expansion of the bioimpedance analyzers market. Obesity, characterized by an excessive accumulation of body fat that adversely affects health, is increasingly prevalent due to the widespread availability of high-calorie, high-fat, and high-sugar foods, along with sedentary lifestyles and decreased physical activity. Bioimpedance analyzers play a crucial role in managing obesity by providing detailed and actionable data on body composition. This information supports personalized treatment plans, monitors health risks, motivates patients, assesses fluid balance, improves clinical outcomes, and enhances research efforts. For instance, in March 2023, the World Heart Foundation, a Switzerland-based cardiovascular community organization, reported that approximately 2.3 billion adults and children globally are obese or overweight. If current trends continue, this number is projected to reach 2.7 billion by 2025. Consequently, increasing concerns about obesity are fueling growth in the bioimpedance analyzers market.
Major companies operating in the bioimpedance analyzers market are emphasizing integration with cloud-based analytics, such as connected, mobile BIA systems that support remote data management and real-time patient monitoring. Connected mobile BIA systems are defined as portable, battery-operated bioimpedance analyzers capable of securely transmitting measurement data to cloud platforms, enabling clinicians to access, analyze, and monitor patients’ body composition and fluid status over time. For instance, in January 2025, SECA, a Germany-based medical device company, introduced the seca mBCA Go, a mobile bioelectrical impedance analyzer that combines its established measuring mat with the seca analytics 125 cloud platform, provides secure patient management capabilities, and integrates with the seca myAnalytics app to support intuitive patient engagement.
In May 2024, Forval Corporation, a Japan-based provider of next-generation management consulting and ICT services, acquired a majority stake in Tanita Health Link, Inc. for an undisclosed amount. Through this acquisition, Forval sought to enhance its presence in the digital health and corporate wellness sector by incorporating Tanita Health Link’s cloud-based health management platforms and communication-enabled measurement devices - commonly used alongside Tanita’s bioimpedance body composition analyzers - into its offerings, thereby advancing data-driven health monitoring and lifestyle intervention solutions for employers, insurers, and municipalities. Tanita Health Link, Inc. is a Japan-based company specializing in web- and app-based health management services as well as communication-capable health and beauty devices.
Major companies operating in the bioimpedance analyzers market are Xiaomi Corporation, Omron Corporation, Beurer GmbH, InBody Co Ltd., Seca GmbH & Co., Withings, Lumsail Industrial Inc., RJL Systems Inc., ImpediMed Limited, Biodynamics Corporation, Charder Electronic Co Ltd., Akern Srl, Bioparhom, BioTekna Limited, Bodystat Ltd., EVOLT 360 Limited, Maltron International Ltd., Tanita Corporation, Tongfang Health Technology (Beijing) Co.Ltd, Jawon Medical Co Ltd.
North America was the largest region in the bioimpedance analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioimpedance analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioimpedance analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the bioimpedance analyzers market by increasing the cost of electronic circuits, sensing electrodes, plastic housings, and wireless communication modules that rely on international component sourcing, resulting in higher device manufacturing and import expenses. The impact is more significant in wireless, multi-frequency, and advanced body composition analyzers, particularly across Asia-Pacific and European production hubs where cross-border component flows are tariff sensitive. Hospitals, fitness clubs, wellness centers, and home user segments are experiencing price pressures and slower procurement cycles due to tariff-driven cost pass-throughs. However, tariffs are also encouraging localized assembly, regional component sourcing, and domestic manufacturing initiatives, which may enhance supply resilience and support long-term market stability.
The bioimpedance analyzers market research report is one of a series of new reports that provides bioimpedance analyzers market statistics, including bioimpedance analyzers industry global market size, regional shares, competitors with a bioimpedance analyzers market share, detailed bioimpedance analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the bioimpedance analyzers industry. This bioimpedance analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Bioimpedance analyzers are devices designed to measure the electrical impedance of biological tissues, primarily for assessing body composition. They operate by passing a small, safe electrical current through the body and measuring how the current's flow is impeded, which varies with different types of tissues.
The primary types of bioimpedance analyzers are multi-frequency, single-frequency, and dual-frequency. Multi-frequency analyzers use various frequencies of electrical current to assess body composition. The available modalities include wired and wireless bioimpedance. These analyzers are applied in whole-body and segmental body measurements, and are used by hospitals, fitness clubs, wellness centers, home users, and others.
The bioimpedance analyzers market consists of sales of bioimpedance spectroscopy, segmental bioimpedance analyzers, handheld bioimpedance analyzers, and clinical-grade bioimpedance analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The bioimpedance analyzers market size is expected to see rapid growth in the next few years. It will grow to $1.28 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing prevalence of obesity and metabolic disorders, growing demand for personalized health and fitness tracking, higher adoption of wireless and connected bioimpedance analyzers, rising use of multi-frequency analyzers for advanced body composition insights, expanding home user and remote health monitoring applications. Major trends in the forecast period include increasing use of bioimpedance analyzers for body composition monitoring, growing adoption in fitness, wellness, and weight management programs, rising utilization in clinical and hospital-based nutritional assessment, expansion of segmental and whole-body measurement applications, focus on accuracy, convenience, and non-invasive assessment techniques.
The growing concerns over obesity are anticipated to drive the expansion of the bioimpedance analyzers market. Obesity, characterized by an excessive accumulation of body fat that adversely affects health, is increasingly prevalent due to the widespread availability of high-calorie, high-fat, and high-sugar foods, along with sedentary lifestyles and decreased physical activity. Bioimpedance analyzers play a crucial role in managing obesity by providing detailed and actionable data on body composition. This information supports personalized treatment plans, monitors health risks, motivates patients, assesses fluid balance, improves clinical outcomes, and enhances research efforts. For instance, in March 2023, the World Heart Foundation, a Switzerland-based cardiovascular community organization, reported that approximately 2.3 billion adults and children globally are obese or overweight. If current trends continue, this number is projected to reach 2.7 billion by 2025. Consequently, increasing concerns about obesity are fueling growth in the bioimpedance analyzers market.
Major companies operating in the bioimpedance analyzers market are emphasizing integration with cloud-based analytics, such as connected, mobile BIA systems that support remote data management and real-time patient monitoring. Connected mobile BIA systems are defined as portable, battery-operated bioimpedance analyzers capable of securely transmitting measurement data to cloud platforms, enabling clinicians to access, analyze, and monitor patients’ body composition and fluid status over time. For instance, in January 2025, SECA, a Germany-based medical device company, introduced the seca mBCA Go, a mobile bioelectrical impedance analyzer that combines its established measuring mat with the seca analytics 125 cloud platform, provides secure patient management capabilities, and integrates with the seca myAnalytics app to support intuitive patient engagement.
In May 2024, Forval Corporation, a Japan-based provider of next-generation management consulting and ICT services, acquired a majority stake in Tanita Health Link, Inc. for an undisclosed amount. Through this acquisition, Forval sought to enhance its presence in the digital health and corporate wellness sector by incorporating Tanita Health Link’s cloud-based health management platforms and communication-enabled measurement devices - commonly used alongside Tanita’s bioimpedance body composition analyzers - into its offerings, thereby advancing data-driven health monitoring and lifestyle intervention solutions for employers, insurers, and municipalities. Tanita Health Link, Inc. is a Japan-based company specializing in web- and app-based health management services as well as communication-capable health and beauty devices.
Major companies operating in the bioimpedance analyzers market are Xiaomi Corporation, Omron Corporation, Beurer GmbH, InBody Co Ltd., Seca GmbH & Co., Withings, Lumsail Industrial Inc., RJL Systems Inc., ImpediMed Limited, Biodynamics Corporation, Charder Electronic Co Ltd., Akern Srl, Bioparhom, BioTekna Limited, Bodystat Ltd., EVOLT 360 Limited, Maltron International Ltd., Tanita Corporation, Tongfang Health Technology (Beijing) Co.Ltd, Jawon Medical Co Ltd.
North America was the largest region in the bioimpedance analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioimpedance analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioimpedance analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the bioimpedance analyzers market by increasing the cost of electronic circuits, sensing electrodes, plastic housings, and wireless communication modules that rely on international component sourcing, resulting in higher device manufacturing and import expenses. The impact is more significant in wireless, multi-frequency, and advanced body composition analyzers, particularly across Asia-Pacific and European production hubs where cross-border component flows are tariff sensitive. Hospitals, fitness clubs, wellness centers, and home user segments are experiencing price pressures and slower procurement cycles due to tariff-driven cost pass-throughs. However, tariffs are also encouraging localized assembly, regional component sourcing, and domestic manufacturing initiatives, which may enhance supply resilience and support long-term market stability.
The bioimpedance analyzers market research report is one of a series of new reports that provides bioimpedance analyzers market statistics, including bioimpedance analyzers industry global market size, regional shares, competitors with a bioimpedance analyzers market share, detailed bioimpedance analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the bioimpedance analyzers industry. This bioimpedance analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Bioimpedance analyzers are devices designed to measure the electrical impedance of biological tissues, primarily for assessing body composition. They operate by passing a small, safe electrical current through the body and measuring how the current's flow is impeded, which varies with different types of tissues.
The primary types of bioimpedance analyzers are multi-frequency, single-frequency, and dual-frequency. Multi-frequency analyzers use various frequencies of electrical current to assess body composition. The available modalities include wired and wireless bioimpedance. These analyzers are applied in whole-body and segmental body measurements, and are used by hospitals, fitness clubs, wellness centers, home users, and others.
The bioimpedance analyzers market consists of sales of bioimpedance spectroscopy, segmental bioimpedance analyzers, handheld bioimpedance analyzers, and clinical-grade bioimpedance analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Bioimpedance Analyzers Market Characteristics
3. Bioimpedance Analyzers Market Supply Chain Analysis
4. Global Bioimpedance Analyzers Market Trends and Strategies
5. Bioimpedance Analyzers Market Analysis of End Use Industries
7. Global Bioimpedance Analyzers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Bioimpedance Analyzers Total Addressable Market (TAM) Analysis for the Market
9. Bioimpedance Analyzers Market Segmentation
10. Bioimpedance Analyzers Market Regional and Country Analysis
11. Asia-Pacific Bioimpedance Analyzers Market
12. China Bioimpedance Analyzers Market
13. India Bioimpedance Analyzers Market
14. Japan Bioimpedance Analyzers Market
15. Australia Bioimpedance Analyzers Market
16. Indonesia Bioimpedance Analyzers Market
17. South Korea Bioimpedance Analyzers Market
18. Taiwan Bioimpedance Analyzers Market
19. South East Asia Bioimpedance Analyzers Market
20. Western Europe Bioimpedance Analyzers Market
21. UK Bioimpedance Analyzers Market
22. Germany Bioimpedance Analyzers Market
23. France Bioimpedance Analyzers Market
24. Italy Bioimpedance Analyzers Market
25. Spain Bioimpedance Analyzers Market
26. Eastern Europe Bioimpedance Analyzers Market
27. Russia Bioimpedance Analyzers Market
28. North America Bioimpedance Analyzers Market
29. USA Bioimpedance Analyzers Market
30. Canada Bioimpedance Analyzers Market
31. South America Bioimpedance Analyzers Market
32. Brazil Bioimpedance Analyzers Market
33. Middle East Bioimpedance Analyzers Market
34. Africa Bioimpedance Analyzers Market
36. Bioimpedance Analyzers Market Competitive Landscape and Company Profiles
37. Bioimpedance Analyzers Market Other Major and Innovative Companies
40. Bioimpedance Analyzers Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Bioimpedance Analyzers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses bioimpedance analyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bioimpedance analyzers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioimpedance analyzers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Multi Frequency; Single Frequency; Dual Frequency2) By Modality: Wired Bioimpedance; Wireless Bioimpedance
3) By Application: Whole Body Measurement; Segmental Body Measurement
4) By End User: Hospitals; Fitness Clubs And Wellness Centers; Home Users; Other End-Users
Subsegments:
1) By Multi-Frequency: Bioimpedance Analyzers With Multiple Frequency Settings; Multi-Frequency Body Composition Analyzers2) By Single-Frequency: Single-Frequency Bioimpedance Analyzers; Single-Frequency Body Composition Analyzers
3) By Dual-Frequency: Dual-Frequency Bioimpedance Analyzers; Dual-Frequency Body Composition Analyzers
Companies Mentioned: Xiaomi Corporation; Omron Corporation; Beurer GmbH; InBody Co Ltd.; Seca GmbH & Co.; Withings; Lumsail Industrial Inc.; RJL Systems Inc.; ImpediMed Limited; Biodynamics Corporation; Charder Electronic Co Ltd.; Akern Srl; Bioparhom; BioTekna Limited; Bodystat Ltd.; EVOLT 360 Limited; Maltron International Ltd.; Tanita Corporation; Tongfang Health Technology (Beijing) Co.Ltd; Jawon Medical Co Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Bioimpedance Analyzers market report include:- Xiaomi Corporation
- Omron Corporation
- Beurer GmbH
- InBody Co Ltd.
- Seca GmbH & Co.
- Withings
- Lumsail Industrial Inc.
- RJL Systems Inc.
- ImpediMed Limited
- Biodynamics Corporation
- Charder Electronic Co Ltd.
- Akern Srl
- Bioparhom
- BioTekna Limited
- Bodystat Ltd.
- EVOLT 360 Limited
- Maltron International Ltd.
- Tanita Corporation
- Tongfang Health Technology (Beijing) Co.Ltd
- Jawon Medical Co Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.76 Billion |
| Forecasted Market Value ( USD | $ 1.28 Billion |
| Compound Annual Growth Rate | 13.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
